🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

BioCentury and BayHelix will bring the 4th East-West Biopharma Summit back to Singapore in March 2025. Please join us for this exclusive event designed for VCs and #biopharma decision-makers. Register for #BioCenturyEastWest with early bird rates: loom.ly/WqidFHU

In an exclusive conversation with BioCentury, Jim Wilson describes how he plans to use newly launched GemmaBio as a vehicle to create a sustainable model for ultrarare disease gene therapies by capitalizing on efficiencies gained from a platform model. biocentury.com/article/653189

Industry KOLs at #BioCenturyGrandRounds will discuss new targets, biomarkers, and advanced tools like EEG & fMRI for treating neurodegenerative & neuropsychiatric diseases in this panel on multi-omics & human data innovation. Learn more: biocenturygrandrounds.com

Asking for a friend, has "North Star" knocked "Perfect Storm" off its perch as the most popular metaphor for the C-Suite and their communications teams? And what would happen if your North Star meets your Perfect Storm?

Grand Rounds preview: Eyes on the target. BioCentury’s inaugural R&D meeting aims to help innovators, investors create a new network linking academic discovery, translation buff.ly/3ACoEBV

Biotech IPO buzz, pharma deal trends, Washington update — a BioCentury podcast buff.ly/47568Ot

Spots are now SOLD OUT for the #BioCenturyGrandRounds poster session, with 40+ early stage biotechs and academic innovators selected by BioCentury to share their science at the conference in Nashville. Register and learn more at biocenturygrandrounds.com.

House to vote on #Biosecure Act soon after it returns on 9/9, but its fate will be determined in the Senate in the lame duck. Separately, the WH has OK'd an "anomaly" that cld put pediatric priority review vouchers in a stop-gap budget bill. Details ($): biocentury.com/article/653416

Eyes on the Target: In this year's Back to School essays, BioCentury asks whether the era of human first, causal biology and personalized medicine can reshape drug discovery to solve the weakest link in biotech -- translation to the clinic. buff.ly/3z4Xvae

Incubated by Samsara, led by ex $GILD liver disease top cat Mani Subramanian, OrsoBio now has $164M+ after a series B co-led by Ascenta, Woodline. BioCentury's Paul Bonanos spoke w/ Mani last fall about modulating energy to address obesity, diabetes & more biocentury.com/article/650574

Last Call for Advanced Rate Discount for 11th BioCentury-BayHelix China Healthcare Summit (Shanghai, Oct. 30-Nov. 1). Register by Sept. 30 to save: conferences.biocentury.com/china-healthca… Can't join in Shanghai? Register for a Digital Pass instead.

Beating the bear: 4Q24 Public Markets Preview on a new #BioCenturyThisWeek podcast. Plus: Introducing this year’s China Summit, and what’s eating U.S. FDA’s advisory committees? with Stephen Hansen 🇺🇦 @BiopharmaJosh @SteveUsdin1 @Jeff_Cranmer buff.ly/4eP0XVy

It was great joining the BioCentury This Week podcast to talk shop with ⁦Jeff Cranmer⁩ about our 11th China Healthcare Summit + Cincinnati chili, Kentucky bourbon & Bengals/Ravens - How about that list? Give a listen on your morning run or walk! podcasts.apple.com/us/podcast/bio…

Are you attending London Life Sciences Week? If so, join BioCentury and BioIndustry Association (BIA) Nov. 19 (5pm-9pm) for our 2nd CEO and Investor Dialogue and networking reception. Includes fireside chat w/ E. Eric Tokat of Centerview. conferences.biocentury.com/jefferies-uk-2… Hope to see you there! #LLSW2024

Early Bird for BioCentury's 4th East-West Biopharma Summit ends Dec. 31. Join us in Singapore, March 2025, for a #biotech CEO & Investor conference focused on the emerging Arc of Innovation across Asia. ✅Register: conferences.biocentury.com/east-west-summ… #BioCenturyEastWest

Looking for investors? No #biotech event attracts more VCs than #BioEquityEurope. Join us May 12-14 in Bruges, Belgium, to celebrate the 25th edition of this destination event for CEOs and investors. BioEquityEurope.com

Debate key bottlenecks in translation. Join us June 4-6 in Chicago (after #ASCO25) for 2nd BioCentury Grand Rounds R&D Conference. We will also host a European edition, Sept. 17-19, Cambridge, U.K. Hope to see you there! #BioCenturyGrandRounds conferences.biocentury.com/grand-rounds-us

A new way of thinking about academia-industry collaboration — a special #BioCenturyGrandRounds edition of the #BioCenturyThisWeek podcast featuring Simone Fishburn 🎗️ & Josh Berlin, top BioCentury analysts and special guests buff.ly/VC9BUzN

Asia deals: Globalization is open for business. An analysis of 198 Asia deals in the last 2.5 years finds Western biotechs are engaging even more than pharmas. A breakdown of deal values, therapeutic areas, modalities and first-in-class potential. buff.ly/ecWluUy